STVN Stevanato Group S.p.A.
Healthcare$17.97-0.22%ClosedMarket Cap: $4.91B
As of 2026-05-26
Valuation
P/E (TTM)
26.71
PEG
1.45
P/B
2.76
P/S
3.52
EV/EBITDA
15.70
DCF Value
$-7.89
FCF Yield
-0.2%
Div Yield
0.3%
Margins & Returns
Gross Margin
29.0%
Operating Margin
16.6%
Net Margin
11.7%
ROE
9.6%
ROA
5.5%
ROIC
6.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $273.6M | 27.5% | $38.7M | $28.0M | $— | — |
| Q4 null | $343.3M | 30.9% | $66.0M | $47.2M | $— | — |
| FY null | $1.14B | 29.0% | $183.1M | $134.3M | $— | $0.06 |
| Q3 null | $303.2M | 29.2% | $52.7M | $36.1M | $— | — |
| Q2 null | $280.0M | 28.1% | $41.4M | $29.7M | $— | $0.06 |
| Q1 null | $256.6M | 27.2% | $34.6M | $26.5M | $— | — |
| Q4 null | $330.6M | 29.7% | $66.9M | $48.3M | $— | — |
| FY null | $1.10B | 27.4% | $161.1M | $117.8M | $— | $0.06 |
| Q3 null | $277.9M | 26.8% | $41.0M | $30.0M | $— | — |
| Q2 null | $259.6M | 26.0% | $28.0M | $20.6M | $— | $0.06 |
| Q1 null | $236.0M | 26.4% | $25.3M | $18.8M | $— | — |
| Q4 2023 | $320.6M | 31.8% | $64.0M | $45.2M | $0.17 | — |